Takeda Pharmaceutical Company Limited Share Price Wiener Boerse
Equities
TKD
JP3463000004
Pharmaceuticals
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.24 EUR | -0.39% | -1.06% | -5.77% |
05-16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
05-15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Sales 2024 | 4,264B 27.17B 25.13B 2,141B | Sales 2025 * | 4,097B 26.11B 24.15B 2,057B | Capitalization | 6,486B 41.34B 38.23B 3,257B |
---|---|---|---|---|---|
Net income 2024 | 144B 918M 849M 72.34B | Net income 2025 * | 136B 865M 800M 68.15B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.03B 22.23B 1,893B | Net Debt 2025 * | 4,204B 26.79B 24.78B 2,111B | EV / Sales 2025 * | 2.61 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
45.8
x | Employees | 49,095 |
Yield 2024 * |
4.55% | Yield 2025 * |
4.61% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | -0.39% | ||
1 week | -1.06% | ||
Current month | -1.30% | ||
1 month | -3.53% | ||
3 months | -11.20% | ||
6 months | -5.15% | ||
Current year | -5.77% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
Date | Price | Change |
---|---|---|
20/05/24 | 24.33 | -0.94% |
22/05/24 | 24.18 | -0.62% |
21/05/24 | 24.33 | -0.94% |
20/05/24 | 24.56 | +1.03% |
17/05/24 | 24.31 | -0.61% |
End-of-day quote Wiener Boerse, May 20, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 723B | |
+34.28% | 595B | |
-4.27% | 369B | |
+20.08% | 332B | |
+2.88% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.03% | 168B |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock